$114 Million is the total value of DAFNA Capital Management LLC's 66 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 43.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Sell | ATRICURE INC | $10,156,000 | +21.4% | 518,946 | -1.9% | 8.92% | +53.1% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $6,189,000 | +3.8% | 236,119 | -1.0% | 5.44% | +31.0% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $4,597,000 | -15.1% | 221,013 | +33.7% | 4.04% | +7.1% |
| LOXO | Buy | LOXO ONCOLOGY INC | $4,487,000 | +31.6% | 139,722 | +7.3% | 3.94% | +66.0% |
| GLPG | GALAPAGOS NVspon adr | $4,241,000 | -0.7% | 66,068 | 0.0% | 3.73% | +25.2% | |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $4,104,000 | – | 1,133,583 | +100.0% | 3.61% | – |
| XENE | XENON PHARMACEUTICALS INC | $3,959,000 | -4.9% | 514,091 | 0.0% | 3.48% | +19.9% | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $3,723,000 | +7.4% | 98,370 | +7.1% | 3.27% | +35.4% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $3,638,000 | +31.0% | 119,841 | +32.9% | 3.20% | +65.3% |
| DERM | DERMIRA INC | $2,997,000 | -10.3% | 98,800 | 0.0% | 2.63% | +13.1% | |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $2,976,000 | +15.6% | 268,067 | -3.6% | 2.62% | +45.8% |
| PODD | INSULET CORP | $2,769,000 | -7.9% | 73,484 | 0.0% | 2.43% | +16.1% | |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $2,677,000 | +13.9% | 286,298 | +19.1% | 2.35% | +43.7% |
| CYTK | Buy | CYTOKINETICS INC | $2,555,000 | +53.2% | 210,306 | +15.7% | 2.24% | +93.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $2,555,000 | -21.2% | 66,008 | +3.1% | 2.24% | -0.5% |
| ARDX | Sell | ARDELYX INC | $2,471,000 | -12.8% | 173,995 | -20.6% | 2.17% | +9.9% |
| INSULET CORPnote 2.000% 6/1 | $2,457,000 | -1.0% | 2,250,000 | 0.0% | 2.16% | +24.9% | ||
| IBB | New | ISHARES TR NASDQ BIOTECetf | $2,309,000 | – | 8,700 | +100.0% | 2.03% | – |
| TSRO | Sell | TESARO INC | $2,084,000 | -29.5% | 15,500 | -47.5% | 1.83% | -11.1% |
| IMMU | Sell | IMMUNOMEDICS INC | $2,054,000 | +11.5% | 559,674 | -1.3% | 1.80% | +40.7% |
| RDUS | Buy | RADIUS HEALTH INC | $2,048,000 | +2.8% | 53,854 | +46.1% | 1.80% | +29.6% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,034,000 | – | 72,500 | +100.0% | 1.79% | – |
| CARA | Sell | CARA THERAPEUTICS INC | $1,946,000 | -12.7% | 209,522 | -21.5% | 1.71% | +10.1% |
| DSCI | DERMA SCIENCES INC | $1,839,000 | +11.3% | 353,718 | 0.0% | 1.62% | +40.4% | |
| MGNX | Buy | MACROGENICS INC | $1,823,000 | +12.5% | 89,200 | +64.6% | 1.60% | +41.9% |
| BEAT | Sell | BIOTELEMETRY INC | $1,676,000 | +12.8% | 75,000 | -6.2% | 1.47% | +42.2% |
| CDTX | New | CIDARA THERAPEUTICS INC | $1,663,000 | – | 159,918 | +100.0% | 1.46% | – |
| SPNC | SPECTRANETICS CORP | $1,605,000 | -2.3% | 65,496 | 0.0% | 1.41% | +23.3% | |
| TNDM | TANDEM DIABETES CARE INC | $1,557,000 | -71.9% | 724,286 | 0.0% | 1.37% | -64.6% | |
| PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $1,546,000 | +1.4% | 2,500,000 | 0.0% | 1.36% | +27.9% | ||
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $1,524,000 | -32.1% | 350,392 | 0.0% | 1.34% | -14.4% | |
| ITEK | Sell | INOTEK PHARMACEUTICALS CORP | $1,447,000 | -35.7% | 237,135 | -0.0% | 1.27% | -18.8% |
| ADXS | New | ADVAXIS INC | $1,253,000 | – | 175,000 | +100.0% | 1.10% | – |
| QURE | UNIQURE NV | $1,142,000 | -26.8% | 203,907 | 0.0% | 1.00% | -7.7% | |
| JNJ | JOHNSON AND JOHNSON | $1,083,000 | -2.4% | 9,400 | 0.0% | 0.95% | +23.0% | |
| ASND | Buy | ASCENDIS PHARMAsponsored adr | $1,073,000 | +73.6% | 53,000 | +72.4% | 0.94% | +119.3% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $1,002,000 | -61.7% | 45,586 | -63.2% | 0.88% | -51.7% |
| ZGNX | Sell | ZOGENIX INC | $906,000 | -0.3% | 74,538 | -6.3% | 0.80% | +25.8% |
| STXS | STEREOTAXIS INC | $892,000 | -25.3% | 1,372,862 | 0.0% | 0.78% | -5.8% | |
| EXAC | EXACTECH INC | $864,000 | +1.1% | 31,636 | 0.0% | 0.76% | +27.6% | |
| ARQL | New | ARQULE INC | $843,000 | – | 668,735 | +100.0% | 0.74% | – |
| Buy | NEURODERM LTD | $842,000 | +215.4% | 37,921 | +163.0% | 0.74% | +297.8% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS | $812,000 | -46.3% | 196,500 | +5.4% | 0.71% | -32.2% |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $722,000 | -38.7% | 101,841 | 0.0% | 0.63% | -22.7% | |
| ELOS | SYNERON MEDICAL LTD | $722,000 | +17.4% | 85,947 | 0.0% | 0.63% | +48.1% | |
| CGNT | COGENTIX MEDICAL INC | $710,000 | +10.4% | 353,482 | 0.0% | 0.62% | +39.3% | |
| IRONWOOD PHARMACEUTICALS INCdbcv 2.250% 6/1 | $690,000 | -3.8% | 600,000 | 0.0% | 0.61% | +21.4% | ||
| CNCE | CONCERT PHARMACEUTICALS INC | $689,000 | +1.8% | 66,968 | 0.0% | 0.60% | +28.2% | |
| MASI | MASIMO CORPORATION | $674,000 | +13.3% | 10,000 | 0.0% | 0.59% | +43.0% | |
| INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 added | $618,000 | -22.2% | 600,000 | 0.0% | 0.54% | -1.8% | ||
| ABUS | New | ARBUTUS BIOPHARMA CORP | $573,000 | – | 234,000 | +100.0% | 0.50% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $555,000 | +36.4% | 9,000 | +50.0% | 0.49% | +72.4% |
| SCYX | Sell | SCYNEXIS INC | $554,000 | -32.8% | 173,645 | -18.6% | 0.49% | -15.3% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $468,000 | -61.2% | 40,192 | -55.3% | 0.41% | -51.0% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $417,000 | – | 65,900 | +100.0% | 0.37% | – |
| ABEO | New | ABEONA THERAPEUTICS INC | $372,000 | – | 76,800 | +100.0% | 0.33% | – |
| PIRS | PIERIS PHARMACEUTICALS INC | $314,000 | -23.0% | 223,325 | 0.0% | 0.28% | -2.8% | |
| Sell | ESSA PHARMA INC | $289,000 | -60.6% | 98,046 | -49.8% | 0.25% | -50.3% | |
| NEOS | NEOS THERAPEUTICS INC | $227,000 | -11.3% | 38,873 | 0.0% | 0.20% | +11.8% | |
| CYAD | CELYADadr | $222,000 | -25.0% | 12,528 | 0.0% | 0.20% | -5.3% | |
| SBPH | New | SPRING BK PHARMACEUTICALS IN | $219,000 | – | 27,412 | +100.0% | 0.19% | – |
| SGYPQ | Sell | SYNERGY PHARMACEUTICALS | $207,000 | -86.3% | 34,000 | -87.6% | 0.18% | -82.7% |
| AVGR | Sell | AVINGER INC | $93,000 | -36.7% | 25,000 | -18.8% | 0.08% | -19.6% |
| GNVC | New | GENVEC INC | $31,000 | – | 9,580 | +100.0% | 0.03% | – |
| BPMX | New | BIOPHARMX CORP | $29,000 | – | 77,031 | +100.0% | 0.02% | – |
| CHEKW | Sell | CHECK CAP LTD*w exp 02/28/202 | $10,000 | -65.5% | 15,250 | -70.2% | 0.01% | -55.0% |
| ETRM | Exit | ENTEROMEDICS INC COM PAR 0.01 | $0 | – | -33,334 | -100.0% | -0.00% | – |
| CVM | Exit | CEL SCI CORP | $0 | – | -127,482 | -100.0% | -0.03% | – |
| GNVC | Exit | GENVEC INC | $0 | – | -95,800 | -100.0% | -0.03% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -70,903 | -100.0% | -0.06% | – |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.08% | – |
| PTN | Exit | PALATIN TECHNOLOGIES INC | $0 | – | -257,193 | -100.0% | -0.11% | – |
| DXTRQ | Exit | DEXTERA SURGICAL INC | $0 | – | -140,275 | -100.0% | -0.18% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.19% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP | $0 | – | -40,000 | -100.0% | -0.21% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -33,100 | -100.0% | -0.32% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -69,300 | -100.0% | -0.33% | – |
| INNL | Exit | INNOCOLL HLDGS PLC | $0 | – | -100,000 | -100.0% | -0.40% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -119,300 | -100.0% | -0.49% | – |
| WINT | Exit | WINDTREE THERAPEUTICS INC | $0 | – | -480,833 | -100.0% | -0.86% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -340,000 | -100.0% | -0.87% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -421,500 | -100.0% | -0.97% | – |
| BSTC | Exit | BIOSPECIFICS TECHNOLOGIES | $0 | – | -39,704 | -100.0% | -1.26% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -46,600 | -100.0% | -1.50% | – |
| CYNA | Exit | CYNAPSUS THERAPEUTICS INC | $0 | – | -230,201 | -100.0% | -6.45% | – |
| VTAE | Exit | VITAE PHARMACEUTICALS INC | $0 | – | -715,988 | -100.0% | -10.43% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.